Top Results for Biotech

Biossance is a pioneer in biotech beauty, known for its high-performance skincare powered by squalane derived from sugarcane. The brand focuses on 'clean' science, creating products that mimic the skin's natural lipids to improve hydration and barrier function. It is ideal for consumers who want cli...

True Botanicals offers a luxury experience centered on high-performance organic skincare. They utilize 'biocompatible' ingredients that work in harmony with the skin's natural processes. Their formulas are designed to be deeply nourishing and effective, providing a spa-like experience at home while...

Ecovative Design utilizes mycelium, the root structure of mushrooms, to create sustainable packaging and materials. Their innovative process replaces traditional plastics and polystyrene with a biodegradable and compostable alternative. This technology offers a compelling solution to the plastic po...

AlphaFold 3 represents a monumental leap forward in predicting the structure of complex biomolecules, including proteins, RNA, and ligands. Utilizing advanced AI techniques, it accurately models interactions between molecules, enabling breakthroughs in drug discovery, materials science, and fundamen...

Katalin Karikó is a biochemist whose pioneering research on modified messenger RNA (mRNA) revolutionized biotechnology. Her work unlocked the potential of mRNA for therapeutic applications and was critical to the rapid development of COVID-19 vaccines. Primarily benefiting medical researchers and ph...

Carl Zeiss Microscopy is a global leader in advanced microscopy solutions. Their systems combine cutting-edge optics, innovative imaging technologies, and intuitive software to empower researchers across diverse fields. From biological research to materials science, Zeiss microscopes provide unparal...

The House of the Scorpion is a 2002 young adult science fiction novel by Nancy Farmer set in Opium, a narco-state carved from territory between a future United States and future Mexico (Aztlán). The protagonist, Matteo Alacrán, discovers he is a clone of the drug lord El Patrón, bred specifically to...

A non-invasive, bio-compatible implant used to store, categorize, and recall vast amounts of non-personal dataeverything from forgotten languages to proprietary schematics. It allows users to maintain multiple, compartmentalized identities without cognitive strain. While incredibly useful for mercen...

Margaret Atwood’s *Oryx and Crake* presents a chilling vision of a future shaped by unchecked biotechnology. The novel details a world ravaged by engineered pandemics following widespread genetic manipulation. It examines the ethical implications of scientific advancement and corporate control. Prim...

Stanley Norman Cohen developed groundbreaking techniques for recombinant DNA technology alongside Herbert Boyer at Stanford University. His work in 1973 established a foundational method for creating recombinant DNA, a critical process within biotechnology and genetic engineering. This innovation en...

Herbert Boyer was a pioneering biochemist whose research fundamentally shaped modern biotechnology. He achieved significant breakthroughs with Stanley Cohen in 1973 demonstrating recombinant DNA cloning – a technique that enabled the creation of genetically engineered organisms. This work led to the...

Katalin Kariko was a Hungarian-American biochemist whose pioneering work with messenger RNA (mRNA) fundamentally advanced vaccine technology. Her research, initially conducted in the late 20th century and continued through the 21st, provided the critical foundation for the rapid development of mRNA...

Alec Jeffreys developed DNA fingerprinting technology during his research at the University of Leicester in 1984. His method uses variations in individual DNA sequences to create unique profiles. This innovation dramatically improved forensic science by providing a more reliable means of identifying...

Yellowfin distinguishes itself with its automated analytics and data storytelling capabilities. It simplifies data exploration and visualization, enabling users to create compelling narratives around data insights. Its collaborative features foster teamwork and knowledge sharing. Designed for a wide...

Baruch S. Blumberg was an American physician, geneticist, and medical researcher whose investigation of human genetic variation led to the identification of the Australia antigen, later recognized as the surface antigen of hepatitis B virus. His work contributed to blood-screening methods and the de...

Drew Weissman is an American physician whose groundbreaking research revolutionized vaccine development. Working with Katalin Kariko, he pioneered the use of modified mRNA to create long-lasting and safer vaccines. His innovative approach addresses immune system challenges, primarily benefiting immu...

*The Island of Doctor Moreau* is an 1896 science fiction novel by H. G. Wells that examines themes of evolution, scientific ethics, and the boundaries of human nature. The story is narrated by Edward Prendick, a shipwrecked man who is rescued and brought to a secluded island. There, he discovers the...

Borne is a 2017 science fiction novel by American author Jeff VanderMeer. Set in a post-apocalyptic, ruined city, the plot centers on Rachel, a scavenger who discovers and raises Borne, a shape-shifting, biotechnological organism. The narrative explores ecological collapse, genetic engineering, and...

"The Year of the Flood" is a 2009 post-apocalyptic science fiction novel by acclaimed Canadian author Margaret Atwood. The story serves as a companion piece to her earlier novel "Oryx and Crake," running concurrently with its timeline while focusing on a different set of characters within the same d...

MaddAddam is a 2013 speculative fiction novel by Margaret Atwood that concludes the dystopian MaddAddam trilogy, following "Oryx and Crake" and "The Year of the Flood". The story focuses on the survivors of a global pandemic as they attempt to rebuild society alongside a genetically engineered human...

"The Lord of Opium" is a 2013 young adult science fiction novel by Nancy Farmer, serving as the sequel to "The House of the Scorpion". The story continues the journey of Matt, a clone who unexpectedly inherits the position of ruler of Opium, a narco-state situated between the United States and what...

Ann Tsukamoto is an American stem-cell researcher who was named on a 1991 patent related to the isolation of human hematopoietic stem cells. Her work contributed to advances in understanding how blood-forming stem cells can be separated from other cells, with implications for cancer research and bon...

Blood Music is a 1985 science fiction novel by Greg Bear, expanded from his 1983 novella of the same name which won the Nebula Award. The story follows a rogue geneticist named Vergil Ulam who injects himself with bio-computers called noocytes when his lab threatens to destroy his research. These ce...

Anne Wojcicki is an American entrepreneur who co-founded 23andMe in 2006 after working in health-care investment on Wall Street. The company became known for direct-to-consumer genetic testing that provided ancestry information and selected health-related reports from a saliva sample. Wojcicki's wor...

This sequel tackles the next frontier: what happens after we solve scarcity? Harari explores humanity's potential trajectory toward becoming data-driven, bio-engineered beings. It examines the rise of AI, genetic manipulation, and the potential obsolescence of the current human model. It is a provoc...

Bloodshot is a 2020 action film centered on a deceased soldier revived with enhanced abilities by an undisclosed group. The narrative depicts the soldier’s subsequent exploitation as a weapon, featuring a cast including Vin Diesel and other actors. Directed by David S. F. Wilson, the movie adapts th...

Experimental AI system that interprets human emotional cues through voice and facial expressions. Still in research phase.

Focuses on gene therapies for rare genetic disorders. Orphan drug designations provide market exclusivity potential.

A clinical-stage biotech developing novel cancer immunotherapies. Recent trial data has sparked investor interest despite high risk.